United States Court of Appeals for the Ninth Circuit Reverses $278M Insulin Royalty Ruling Against Eli Lilly and Company

United States Court of Appeals for the Ninth Circuit Reverses $278M Insulin Royalty Ruling Against Eli Lilly and Company — alphai